Featured Research

from universities, journals, and other organizations

University Of Illinois At Chicago Study Identifies Possible Predictor Of Tamoxifen Resistance

Date:
May 9, 2003
Source:
University Of Illinois At Chicago
Summary:
A discovery from the University of Illinois at Chicago College of Pharmacy may make it possible to anticipate which breast cancer patients will respond to tamoxifen and to devise a more appropriate therapy for those who do not.

A discovery from the University of Illinois at Chicago College of Pharmacy may make it possible to anticipate which breast cancer patients will respond to tamoxifen and to devise a more appropriate therapy for those who do not.

Tamoxifen has been used for more than 25 years to treat patients with certain types of breast cancer. But the drug is not effective for all patients, and until now, doctors and researchers have been unable to predict who would benefit and why.

In an article in the current issue of the British Journal of Cancer, Debra Tonetti, assistant professor of biopharmaceutical sciences in the UIC College of Pharmacy, reports the results of a study that identifies a possible predictor of tamoxifen resistance.

Tamoxifen works by blocking the effect of estrogen, which promotes the growth of breast cancer cells containing the estrogen receptor. However, in a retrospective study, Tonetti found that patients whose disease recurred had high levels of an enzyme called protein kinase C alpha, whereas patients who remained disease-free for at least five years had very low levels of PKC-alpha or none at all.

"Overproduction of PKC-alpha may be used to predict who will not respond to tamoxifen," Tonetti said. "In addition, we found that in mice, tumors that overproduce PKC-alpha completely regress with estrogen treatment."

These findings, her paper states, "may have important therapeutic applications in the management of breast cancer patients."

The initial study used archival biopsied tissue from 30 patients. Tonetti is now expanding her study, funded in part by the National Cancer Institute, and will use tissue from several hundred patients matched by age and disease stage to substantiate the preliminary findings. Upon completion of the entire study, in about 18 months, she hopes to start clinical trials.

"Cancer recurrence is a real problem," she said. "Finding more effective strategies for treating it would be very helpful."

For more information on the UIC College of Pharmacy, visit http://www.uic.edu/pharmacy.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "University Of Illinois At Chicago Study Identifies Possible Predictor Of Tamoxifen Resistance." ScienceDaily. ScienceDaily, 9 May 2003. <www.sciencedaily.com/releases/2003/05/030509084441.htm>.
University Of Illinois At Chicago. (2003, May 9). University Of Illinois At Chicago Study Identifies Possible Predictor Of Tamoxifen Resistance. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2003/05/030509084441.htm
University Of Illinois At Chicago. "University Of Illinois At Chicago Study Identifies Possible Predictor Of Tamoxifen Resistance." ScienceDaily. www.sciencedaily.com/releases/2003/05/030509084441.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins